Index RUT
P/E 15.50
EPS (ttm) 4.17
Insider Own 1.22%
Shs Outstand 49.82M
Perf Week -8.15%
Market Cap 3.23B
Forward P/E 13.71
EPS next Y 4.71
Insider Trans -12.56%
Shs Float 49.31M
Perf Month -5.41%
Income 209.34M
PEG 1.94
EPS next Q 0.86
Inst Own 104.25%
Short Float 3.76%
Perf Quarter -6.49%
Sales 1.13B
P/S 2.87
EPS this Y 4.59%
Inst Trans -2.81%
Short Ratio 7.92
Perf Half Y 10.38%
Book/sh 33.22
P/B 1.95
EPS next Y 7.08%
ROA 6.20%
Short Interest 1.86M
Perf Year 9.15%
Cash/sh 0.93
P/C 69.45
EPS next 5Y 8.00%
ROE 13.50%
52W Range 52.90 - 75.31
Perf YTD 5.60%
Dividend Est. -
P/FCF 13.48
EPS past 5Y -
ROI 7.51%
52W High -14.15%
Beta 0.50
Dividend TTM -
Quick Ratio 2.02
Sales past 5Y 3.08%
Gross Margin 53.48%
52W Low 22.21%
ATR (14) 1.70
Dividend Ex-Date Dec 27, 2013
Current Ratio 3.20
EPS Y/Y TTM 353.29%
Oper. Margin 30.43%
RSI (14) 27.67
Volatility 3.17% 1.97%
Employees 570
Debt/Eq 0.69
Sales Y/Y TTM -0.21%
Profit Margin 18.60%
Recom 1.57
Target Price 74.60
Option/Short Yes / Yes
LT Debt/Eq 0.68
EPS Q/Q 120.35%
Payout 0.00%
Rel Volume 2.02
Prev Close 64.98
Sales Surprise -3.63%
EPS Surprise -10.46%
Sales Q/Q -3.11%
Earnings May 14 AMC
Avg Volume 234.30K
Price 64.65
SMA20 -7.72%
SMA50 -8.77%
SMA200 1.68%
Trades
Volume 473,777
Change -0.51%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-17-22 Initiated
Canaccord Genuity
Buy
$71
May-10-22 Upgrade
Jefferies
Hold → Buy
$65 → $70
May-09-22 Upgrade
Oppenheimer
Perform → Outperform
$63
Aug-07-20 Downgrade
DA Davidson
Buy → Neutral
Jun-29-20 Upgrade
Sidoti
Neutral → Buy
Apr-14-20 Downgrade
Jefferies
Buy → Hold
Apr-07-20 Resumed
Sidoti
Neutral
$46
Mar-26-20 Upgrade
Jefferies
Hold → Buy
$43
Mar-24-20 Initiated
Oppenheimer
Perform
Mar-19-20 Upgrade
DA Davidson
Neutral → Buy
Jan-15-19 Downgrade
Raymond James
Outperform → Mkt Perform
Dec-04-17 Upgrade
William Blair
Mkt Perform → Outperform
Jun-02-17 Upgrade
Jefferies
Underperform → Hold
May-22-17 Upgrade
Raymond James
Mkt Perform → Outperform
Dec-27-16 Reiterated
B. Riley & Co.
Buy
$70 → $77
Nov-17-16 Initiated
Gabelli & Co
Buy
$65
Aug-12-16 Upgrade
Sidoti
Neutral → Buy
Mar-08-16 Initiated
KeyBanc Capital Mkts
Overweight
$60
Feb-05-16 Initiated
Piper Jaffray
Overweight
$58
Nov-30-15 Downgrade
Jefferies
Hold → Underperform
Show Previous Ratings
May-16-24 11:36AM
03:02AM
May-15-24 12:19PM
(Morningstar Research) -7.01%
May-14-24 09:53PM
06:15PM
05:00PM
Loading…
05:00PM
May-09-24 09:15AM
May-06-24 06:17PM
Apr-25-24 10:02AM
08:30AM
Apr-19-24 07:41AM
Apr-08-24 09:40AM
Apr-03-24 11:57AM
Apr-02-24 09:06AM
Mar-25-24 09:50AM
10:40AM
Loading…
Mar-21-24 10:40AM
Mar-05-24 12:55PM
Feb-29-24 09:50AM
Feb-16-24 05:00PM
Feb-08-24 05:34PM
(Morningstar Research) +9.36%
09:30AM
07:10AM
06:34AM
06:00AM
Feb-02-24 09:00AM
Feb-01-24 10:00AM
Jan-29-24 07:22PM
Jan-10-24 05:00PM
Dec-22-23 09:00AM
Nov-29-23 07:08AM
08:30AM
Loading…
Nov-24-23 08:30AM
Nov-08-23 09:40AM
Nov-05-23 01:42PM
Nov-02-23 12:31PM
06:00AM
Oct-05-23 04:30PM
Sep-29-23 09:45AM
Sep-22-23 09:40AM
Sep-19-23 09:00AM
Sep-06-23 09:35AM
Sep-05-23 05:00PM
Aug-16-23 12:45PM
Aug-03-23 09:30AM
07:25AM
06:21AM
06:00AM
Jul-19-23 11:40AM
Jul-11-23 08:00AM
Jul-06-23 04:30PM
Jun-21-23 08:00PM
Jun-16-23 11:40AM
Jun-05-23 09:00AM
Jun-01-23 10:54AM
May-31-23 11:40AM
09:00AM
May-30-23 06:50AM
May-23-23 02:00PM
May-15-23 11:40AM
May-05-23 08:49AM
May-04-23 07:35AM
06:32AM
06:00AM
Apr-26-23 08:00PM
Apr-18-23 08:00AM
Feb-25-23 08:14AM
Feb-02-23 07:15AM
06:00AM
Jan-09-23 08:00AM
Jan-05-23 04:30PM
Jan-02-23 09:06AM
Dec-12-22 12:05PM
Nov-26-22 07:05AM
Nov-09-22 06:37AM
Nov-03-22 07:25AM
06:00AM
Oct-27-22 10:03AM
Oct-04-22 04:30PM
Sep-28-22 09:40AM
Sep-20-22 02:45PM
Sep-18-22 08:26AM
Sep-07-22 05:03PM
Aug-29-22 09:35AM
Aug-23-22 12:00PM
Aug-04-22 07:25AM
06:00AM
Jul-26-22 08:33AM
Jul-11-22 04:30PM
Jun-09-22 08:44AM
May-05-22 08:25PM
04:30PM
Apr-14-22 08:53AM
Apr-11-22 07:12AM
Apr-01-22 09:52PM
Mar-19-22 09:46AM
Mar-17-22 03:08PM
Feb-16-22 11:38AM
Feb-04-22 02:38PM
12:00PM
09:38AM
Feb-03-22 07:15AM
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American and International OTC Healthcare segments manage the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Fritz Mary Beth SVP Quality & Regulatory Mar 01 '24 Option Exercise 40.16 172 6,907 16,044 Mar 05 04:01 PM Fritz Mary Beth SVP Quality & Regulatory Mar 01 '24 Sale 70.42 172 12,112 15,934 Mar 05 04:01 PM Fritz Mary Beth SVP Quality & Regulatory Feb 28 '24 Option Exercise 40.45 662 26,779 16,350 Feb 29 04:01 PM Fritz Mary Beth SVP Quality & Regulatory Feb 28 '24 Sale 70.30 662 46,536 15,934 Feb 29 04:01 PM Fritz Mary Beth SVP Quality & Regulatory Feb 27 '24 Option Exercise 57.18 1 57 15,935 Feb 29 04:01 PM Fritz Mary Beth SVP Quality & Regulatory Feb 27 '24 Sale 70.00 1 70 15,934 Feb 29 04:01 PM Fritz Mary Beth SVP Quality & Regulatory Feb 26 '24 Option Exercise 44.68 9,677 432,343 21,006 Feb 27 04:04 PM Fritz Mary Beth SVP Quality & Regulatory Feb 26 '24 Sale 70.43 9,677 681,597 15,934 Feb 27 04:04 PM Fritz Mary Beth SVP Quality & Regulatory Feb 23 '24 Option Exercise 44.45 23 1,022 15,946 Feb 27 04:04 PM Fritz Mary Beth SVP Quality & Regulatory Feb 23 '24 Sale 70.00 23 1,610 15,934 Feb 27 04:04 PM Mekhail Adel EVP, Marketing & Sales Feb 15 '24 Option Exercise 37.46 15,549 582,489 30,230 Feb 20 04:01 PM Mekhail Adel EVP, Marketing & Sales Feb 15 '24 Sale 69.11 15,549 1,074,645 18,681 Feb 20 04:01 PM P'Pool William See remarks Feb 14 '24 Option Exercise 45.28 26,019 1,178,164 38,600 Feb 16 04:01 PM Sacco Christine Chief Financial Officer Feb 14 '24 Option Exercise 29.46 24,788 730,254 46,526 Feb 16 04:02 PM Sacco Christine Chief Financial Officer Feb 14 '24 Sale 68.35 30,019 2,051,874 21,738 Feb 16 04:02 PM P'Pool William See remarks Feb 14 '24 Sale 67.90 26,019 1,766,665 24,917 Feb 16 04:01 PM Fritz Mary Beth SVP Quality & Regulatory Feb 08 '24 Option Exercise 56.11 5,336 299,403 21,270 Feb 12 12:08 PM Fritz Mary Beth SVP Quality & Regulatory Feb 08 '24 Sale 69.00 5,336 368,184 15,934 Feb 12 12:08 PM Fritz Mary Beth SVP Quality & Regulatory Sep 14 '23 Option Exercise 30.56 2,540 77,622 18,474 Sep 15 04:03 PM Fritz Mary Beth SVP Quality & Regulatory Sep 14 '23 Sale 58.92 2,540 149,657 15,934 Sep 15 04:03 PM Lombardi Ronald M. Chief Executive Officer Aug 08 '23 Option Exercise 33.50 32,800 1,098,800 303,357 Aug 09 04:01 PM Lombardi Ronald M. Chief Executive Officer Aug 08 '23 Sale 65.57 32,800 2,150,536 270,557 Aug 09 04:01 PM Sacco Christine Chief Financial Officer May 24 '23 Option Exercise 50.05 37,029 1,853,192 70,980 May 26 04:04 PM Sacco Christine Chief Financial Officer May 24 '23 Sale 60.07 55,294 3,321,511 26,969 May 26 04:04 PM Mekhail Adel EVP, Marketing & Sales May 19 '23 Option Exercise 30.19 17,194 519,087 28,681 May 22 04:05 PM Mekhail Adel EVP, Marketing & Sales May 19 '23 Sale 62.36 17,194 1,072,286 18,681 May 22 04:05 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite